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NC-ND license (http://creativecommoTuberous sclerosis (TS) is an autosomal dominant condition associated with mutations in the
TSC1 and/or TSC2 genes. Clinical manifestations are multisystemic, and they often include le-
sions in the brain, skin, heart, kidneys, and bones. TSC2 gene mutations can be seen concom-
itantly with autosomal dominant polycystic kidney disease gene mutations. We present a case
of a fetus with prenatal diagnosis of TS that had unique asymmetrical distribution of renal
cystic disease. We describe the extensive work up with both fetal and neonatal magnetic reso-
nance imaging with correlating images of the unilateral polycystic renal disease in addition to
typical TS brain findings.
Copyright ª 2014, Taiwan Pediatric Association. Published by Elsevier Taiwan LLC. This is an
open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/
by-nc-nd/4.0/).1. Introduction
Tuberous sclerosis (TS) is a multisystemic disease that
manifests with the growth of benign hamartomas in variousing authors declare no con-
niversity School of Medicine,
0016, USA.
.nyu.edu (V. Tyagi).
013.10.014
ediatric Association. Published by
ns.org/licenses/by-nc-nd/4.0/).organ systems, including the central nervous system, kid-
neys, and skin. TS has an incidence rate of roughly 1 in 6000
newborns and affects over 1.5 million people globally. TS is
an autosomal dominant disorder caused by the TSC1 and
TSC2 genes, which are located on chromosomes 9 and 16,
respectively. TS development generally requires a combi-
nation of events, the first of which is a germline mutation
that results in a loss of heterozygosity for an allele of either
gene. The subsequent events necessary for TS manifesta-
tion are somatic mutations that cause the loss of the other
TS allele. Patients with TS often manifest brain lesionsElsevier Taiwan LLC. This is an open access article under the CC BY-
MRI in a neonate with tuberous sclerosis 441(cortical/subcortical tubers, subependymal nodules, and
subependymal giant cell tumors), angiomyolipomas, renal
cysts, and skeletal lesions.1
The diagnosis of TS requires a combination of either two
major criteria, or one major and two minor criteria. TS may
also be diagnosed based on the presence of TS-associated
lesions in two different organs, or two differing types of
lesions within the same organ. Probable TS is diagnosed by
one major and one minor feature, and TS may be suspected
in the presence of either one major or two minor features.
The most common major features are cortical tubers, facial
angiofibromas, nontraumatic ungual or periungual fi-
bromas, hypomelanotic macules (>3), shagreen patches,
subependymal nodules, subependymal giant cell tumors,
cardiac rhadomyoma (1), lymphangioleiomyomatosis, and
renal angiomyolipomas. The minor features include pits in
dental enamel, hamartomatous renal polyps, skeletal cysts,
white matter migration tracts, gingival fibromas, nonrenal
hamartoma, renal achromic patches, skin lesions, multiple
renal cysts, and infantile spasms.22. Case report
A 28-year-old pregnant woman at 39 weeks of gestation was
referred for fetal magnetic resonance imaging (MRI) to
evaluate intracranial abnormalities that might support the
prenatal diagnosis of TS. The fetus had just completed
routine 3rd trimester sonographic evaluation where several
fetal intracardiac masses with the sonographic appearance
of rhabdomyomas were detected incidentally. Focused
imaging of the fetal brain demonstrated subependymal
nodules and cortical/subcortical signal abnormalities
consistent with tubers (Figure 1). These findings confirmedFigure 1 (A,B) Axial Half Fourier-Acquired Single Shot Turbo Spin
resonance scan demonstrating T2 hypointense and T1 hyperintens
cortical/subcortical tubers (white arrows). (E,F) Axial T2 and (G,H)
demonstrating T2 hypointense and T1 hyperintense subependymal
tical tubers (white arrows).the diagnosis of TS. On scout images for the fetal MRI, an
abnormal T2 hyperintensity was seen within the fetal
abdomen. After dedicated imaging of the fetal brain,
focused fetal body MRI images were obtained. It was noted
that the right kidney was abnormally enlarged and had a
lobulated mass-like appearance (Figure 2) with moderate
T2/Half Fourier-Acquired Single Shot Turbo Spin Echo
(HASTE) hyperintensity. No T1 hyperintensity was seen
within the right kidney. The left kidney was normal in
appearance. Given the unilaterality and the moderate T2
isointensity, a differential diagnosis for the appearance of
the right kidney was given. Both solid and cystic masses
such as mesoblastic nephroma and lipid poor angiomyoli-
poma were included. The couple denied any family history
consistent with TS and the patient was counseled by both
maternal fetal medicine and genetics specialists regarding
these findings.
Following uncomplicated spontaneous vaginal delivery,
postnatal MRI of the brain confirmed the prenatal findings
of subependymal nodules and cortical/subcortical tubers
(Figure 1). Postnatal sonography of the kidneys demon-
strated an enlarged right kidney with a polycystic appear-
ance and a left kidney that appeared to be normal
(Figure 2). The neonate was discharged home in good
medical condition and follow-up was scheduled in a
specialized TS clinic.
A follow-up ultrasound was performed at age 2 months,
and there was an overall decrease in the size of the mul-
tiple cysts; however, there was a persistent unilateral
polycystic appearance (Figure 3). MRI of the kidneys
demonstrated a unilateral segmentally distributed polycy-
stic appearance to the right kidney interspersed with more
normally appearing renal parenchyma with a preserved
corticomedullary appearance in focal areas. The rightEcho (HASTE) and (C,D) Axial T1 images from a fetal magnetic
e subependymal nodules (white arrow with black outline) and
Axial T1 images from the postnatal magnetic resonance imaging
nodules (white arrow with black outline) and cortical/subcor-
Figure 2 (A,B) Axial, (C) sagittal, and (D) coronal Half Fourier-Acquired Single Shot Turbo Spin Echo (HASTE) images through the
fetal body demonstrating a large hyperintense lobulated appearance of the fight kidney (black arrows) with areas of normal-
appearing renal parenchyma (white arrow with black outline). The left kidney has a normal appearance. Postnatal sonography
of the right kidney (E) as a newborn and (F) at age 2 months. The kidney is enlarged and echogenic with focal areas of small cyst
formation (arrows) and areas of relative sparing (white arrowhead) seen.
442 V. Tyagi et alkidney demonstrated normal enhancement and excretion
of intravenous contrast. The left kidney appeared normal
with a single tiny cyst being noted (Figure 3).
The clinical course of the neonate has been uncompli-
cated, with no evidence of seizure activity, electroen-
cephalogram abnormality, or laboratory evidence of renal
dysfunction up to this point. The renal function of this child
is normal as evidenced by blood urea nitrogen and creati-
nine of 8 mg/dL and 0.2 mg/dL, respectively, at age 14
months, and 12 mg/dL and 0.3 mg/dL, respectively, at age
30 months. Her electrolytes are normal. There has been no
indication for additional imaging or renal function tests. To
date, the parents have not undergone genetic testing for
themselves or for their child.3. Discussion
This is a unique case of TS with unilateral renal polycystic
disease presenting in utero. The presence of renal cysts in
TS may be due to the proximity of the autosomal dominant
polycystic kidney disease (ADPKD) gene, PKD1, to the TSC
gene located on chromosome 16. Because these genes are
adjacent, a mutation in the TSC gene may also have effects
on the ADPKD gene. ADPKD typically presents as bilateral
development of cysts in the kidneys. It ultimately leads to
end-stage renal failure in the majority of patients. Cyst
development is not limited exclusively to the kidneys; it
may also be seen in other organs such as the liver,
pancreas, and spleen.3There are two key genes that are postulated to be
involved in ADPKD. The PKD1 gene encodes for polycystin-1,
which is an integral membrane protein; in vitro studies
have shown that this glycoprotein localizes to lateral cell
junctions and is responsible for mediation of intercellular
adhesion. The PKD2 gene, which is located on chromosome
4, encodes polycystin-2. It has also been shown that al-
terations in TSC2 can cause the loss of function of
polycystin-1. The presence of extensive cystic disease
suggests that the patient also has polycystic kidney disease
in addition to tuberous sclerosis. These findings indicate
that she probably has the dual manifestation known as TSC2
and PKD1 contiguous gene syndrome.4 Renal cystic disease
associated with TS typically is present bilaterally, and
unilateral manifestations are rare.5,6 In the few cases that
are described in the literature, pathology specimens have
demonstrated glomerulocystic kidney disease and the most
recent case suggested mammalian target of rapamycin-
positive epithelial cells within these cysts. Interestingly,
mammalian target of rapamycin inhibitors have been used
both in the treatment of subependymal giant cell astrocy-
tomas associated with TS as well as in clinical trials for
ADPKD.7,8
In our case, fetal MRI initially demonstrated typical brain
findings of TS and the enlarged and cystic appearance of
the right kidney. Postnatal ultrasound and MRI confirmed
brain abnormalities and demonstrated the unilateral renal
polycystic appearance with areas of interspersed normally
appearing renal parenchyma. Normal enhancement and
excretion suggest significant function of the affected
Figure 3 (A,B) Coronal T2 and (C) Axial T2 images through the kidneys demonstrate small cysts replacing right renal parenchyma
(arrows), with focal areas of sparing (arrowhead). (D) Coronal T1 postcontrast image demonstrating parenchymal renal
enhancement without a solid right renal mass.
MRI in a neonate with tuberous sclerosis 443kidney. Although the only other report of unilateral renal
cystic disease in an infant was a pathology description
status post nephrectomy,5 it was determined that given the
significant function of this kidney, a nephrectomy was un-
necessary at this time. The patient will be closely followed
for renal and neurologic function. As the patient is
currently asymptomatic, she is not receiving any current
medication.
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